Skip to main content
logo
Pharmadrug Inc. (CSE:PHRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.0150
0.00 (0.00%)
May 1, 2026, 9:30 AM EST

Pharmadrug Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----0.01
Revenue Growth (YoY)
-----98.98%
Cost of Revenue
---00.01
Gross Profit
----0-0
Selling, General & Admin
0.160.40.781.271.55
Research & Development
-0.140.230.710.55
Amortization of Goodwill & Intangibles
0.050.050.03--
Operating Expenses
0.210.631.362.352.72
Operating Income
-0.21-0.63-1.36-2.36-2.72
Interest Expense
-0.31-0.27-0.33-0.22-0.06
Currency Exchange Gain (Loss)
-000-0.73
Other Non Operating Income (Expenses)
0.08-0.05-0.06-0.05-0.06
EBT Excluding Unusual Items
-0.43-0.95-1.76-2.62-3.57
Merger & Restructuring Charges
---1.43--
Gain (Loss) on Sale of Investments
--0.01-0.05-0.61-0.72
Asset Writedown
---10.14--
Legal Settlements
-0.130.07-0.07-
Other Unusual Items
--0.04-0.960.05-
Pretax Income
-0.43-0.87-14.27-3.25-4.28
Income Tax Expense
---1.01-0.19-
Earnings From Continuing Operations
-0.43-0.87-13.26-3.06-4.28
Earnings From Discontinued Operations
----5.81-1.59
Net Income to Company
-0.43-0.87-13.26-8.88-5.87
Minority Interest in Earnings
0.050.080.06-0.25
Net Income
-0.38-0.79-13.2-8.88-5.63
Net Income to Common
-0.38-0.79-13.2-8.88-5.63
Shares Outstanding (Basic)
108104565047
Shares Outstanding (Diluted)
108104565047
Shares Change (YoY)
4.03%83.99%12.76%5.88%132.48%
EPS (Basic)
-0.00-0.01-0.23-0.18-0.12
EPS (Diluted)
-0.00-0.01-0.23-0.18-0.12
Free Cash Flow
-0.09-0.76-0.67-2.26-4.13
Free Cash Flow Per Share
-0.00-0.01-0.01-0.04-0.09
Gross Margin
-----30.75%
Operating Margin
-----38806.68%
Profit Margin
-----80275.25%
Free Cash Flow Margin
-----58906.35%
EBITDA
-0.16-0.58-1.34-2.34-2.72
D&A For EBITDA
0.050.050.030.010
EBIT
-0.21-0.63-1.36-2.36-2.72
Source: S&P Global Market Intelligence. Standard template. Financial Sources.